Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin

Abstract Background Gallbladder cancer (GBC) is likely to be diagnosed at progressive stages and shows a very poor prognosis. Combination therapy with gemcitabine and cisplatin (GEMCIS) has been widely used as first-line palliative chemotherapy for advanced GBC. This study was designed to investigat...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Min su You, Ji Kon Ryu, Young Hoon Choi, Jin Ho Choi, Gunn Huh, Woo Hyun Paik, Sang Hyub Lee, Yong-Tae Kim
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2019-01-01
Serija:	BMC Cancer
Teme:	Gallbladder neoplasms Gemcitabine Cisplatin Prognosis Treatment outcome
Online dostop:	http://link.springer.com/article/10.1186/s12885-018-5211-y
Oznake:	Označite Brez oznak, prvi označite!